Search Page

1

Cite

Share

Polio by the Numbers - A Global Perspective.

Badizadegan K, Kalkowska DA, Thompson KM. Badizadegan K, et al. Among authors: thompson km. J Infect Dis. 2022 Apr 13:jiac130. doi: 10.1093/infdis/jiac130. Online ahead of print. J Infect Dis. 2022. PMID: 35415741

Cite

Share

2

Cite

Share

Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative.

Thompson KM, Kalkowska DA, Badizadegan K. Thompson KM, et al. Among authors: badizadegan k. Gates Open Res. 2022 Feb 3;6:5. doi: 10.12688/gatesopenres.13524.1. eCollection 2022. Gates Open Res. 2022. PMID: 35280345 Free PMC article.

Cite

Share

3

Cite

Share

Health economic analyses of secondary vaccine effects: a systematic review and policy insights.

Thompson KM, Badizadegan K. Thompson KM, et al. Among authors: badizadegan k. Expert Rev Vaccines. 2022 Mar;21(3):297-312. doi: 10.1080/14760584.2022.2017287. Epub 2022 Jan 12. Expert Rev Vaccines. 2022. PMID: 34927511

Cite

Share

4

Cite

Share

Polio eradication: what kind of world do we want?

Thompson KM. Thompson KM. Lancet Infect Dis. 2022 Feb;22(2):161-163. doi: 10.1016/S1473-3099(21)00458-8. Epub 2021 Oct 11. Lancet Infect Dis. 2022. PMID: 34648732 Free PMC article. No abstract available.

Cite

Share

5

Cite

Share

Modeling Poliovirus Surveillance and Immunization Campaign Quality Monitoring Costs for Pakistan and Afghanistan for 2019-2023.

Kalkowska DA, Pallansch MA, Cochi SL, Thompson KM. Kalkowska DA, et al. Among authors: thompson km. Open Forum Infect Dis. 2021 May 23;8(7):ofab264. doi: 10.1093/ofid/ofab264. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34295942 Free PMC article.

Cite

Share

6

Cite

Share

Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.

Kalkowska DA, Pallansch MA, Wassilak SGF, Cochi SL, Thompson KM. Kalkowska DA, et al. Among authors: thompson km. Vaccine. 2021 May 13:S0264-410X(21)00543-0. doi: 10.1016/j.vaccine.2021.04.061. Online ahead of print. Vaccine. 2021. PMID: 33994237 Free article.

Cite

Share

7

Cite

Share

The impact of disruptions caused by the COVID-19 pandemic on global polio eradication.

Kalkowska DA, Voorman A, Pallansch MA, Wassilak SGF, Cochi SL, Badizadegan K, Thompson KM. Kalkowska DA, et al. Among authors: thompson km, badizadegan k. Vaccine. 2021 Apr 27:S0264-410X(21)00473-4. doi: 10.1016/j.vaccine.2021.04.026. Online ahead of print. Vaccine. 2021. PMID: 33962838 Free article.

Cite

Share

8

Cite

Share

Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine Options.

Kalkowska DA, Pallansch MA, Cochi SL, Thompson KM. Kalkowska DA, et al. Among authors: thompson km. J Infect Dis. 2021 Nov 16;224(9):1529-1538. doi: 10.1093/infdis/jiab160. J Infect Dis. 2021. PMID: 33885734 Free PMC article.

Cite

Share

9

Cite

Share

Hypothetical emergence of poliovirus in 2020: part 1. Consequences of policy decisions to respond using nonpharmaceutical interventions.

Thompson KM, Kalkowska DA, Badizadegan K. Thompson KM, et al. Among authors: badizadegan k. Expert Rev Vaccines. 2021 Apr;20(4):465-481. doi: 10.1080/14760584.2021.1891888. Epub 2021 May 5. Expert Rev Vaccines. 2021. PMID: 33624568 Review.

Cite

Share

10

Cite

Share

Hypothetical emergence of poliovirus in 2020: part 2. exploration of the potential role of vaccines in control and eradication.

Thompson KM, Kalkowska DA, Badizadegan K. Thompson KM, et al. Among authors: badizadegan k. Expert Rev Vaccines. 2021 Apr;20(4):449-460. doi: 10.1080/14760584.2021.1891889. Epub 2021 May 5. Expert Rev Vaccines. 2021. PMID: 33599178 Review.

Cite

Share